scispace - formally typeset
A

Anne D. Zurn

Researcher at University of Lausanne

Publications -  35
Citations -  4218

Anne D. Zurn is an academic researcher from University of Lausanne. The author has contributed to research in topics: Neurotrophic factors & Glial cell line-derived neurotrophic factor. The author has an hindex of 29, co-authored 35 publications receiving 4133 citations. Previous affiliations of Anne D. Zurn include University Hospital of Lausanne.

Papers
More filters
Journal ArticleDOI

Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients.

TL;DR: It is demonstrated that neurotrophic factors can be continuously delivered within the CSF of humans by an ex vivo gene therapy approach, opening new avenues for the treatment of neurological diseases.
Journal ArticleDOI

Isolation of multipotent neural precursors residing in the cortex of the adult human brain.

TL;DR: The results indicate that the study of adult multipotent precursors is a new platform to study adult human neurogenesis, potentially generate neural cells for transplantation, and design protocols for in vivo stimulation.
Journal ArticleDOI

Self-Inactivating Lentiviral Vectors with Enhanced Transgene Expression as Potential Gene Transfer System in Parkinson's Disease

TL;DR: In this article, a self-inactivating (SIN) lentiviral vector was modified by insertion of the posttranscriptional regulatory element of the woodchuck hepatitis virus, and particles were produced with a multiply attenuated packaging system.
Journal ArticleDOI

GDNF and NGF released by synthetic guidance channels support sciatic nerve regeneration across a long gap.

TL;DR: S sustained delivery of GDNF and NGF to the injury site, by synthetic nerve guidance channels, allows regeneration of both sensory and motor axons over long gaps; GDNF leads to better overall regeneration in the sciatic nerve.
Journal ArticleDOI

Lentiviral vectors as a gene delivery system in the mouse midbrain : Cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF

TL;DR: In this paper, a lentiviral vector was validated as a gene delivery system in the mouse midbrain in the perspective of screening biotherapeutic molecules in mouse models of Parkinson's disease.